1.
Monika Wołosik, Natalia Bednarczyk, Rafał Bednarczyk, Radosław Krzysztof Binkowski, Agnieszka Kurek, Natalia Krajewska, et al. COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. IJITSS [Internet]. 2026 Jan. 17 [cited 2026 May 2];1(1(49). Available from: https://rspublisher.org/index.php/ijitss/article/view/4695